← Back to Search

ComBaT for Glaucoma

N/A
Waitlist Available
Led By Angela Elam
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 14 months
Awards & highlights

Study Summary

This trial looks into if more resources can help people get eye care to prevent blindness and glaucoma.

Who is the study for?
This trial is specifically for Black or African American individuals who have already taken part in the screening exam phase of the study. It aims to see if extra support and education can encourage them to regularly visit eye care professionals, potentially preventing blindness due to glaucoma.Check my eligibility
What is being tested?
The ComBaT Glaucoma intervention is being tested to determine whether providing additional resources and education can improve a person's likelihood of seeking regular eye care services, which could help prevent vision loss from glaucoma.See study design
What are the potential side effects?
Since this trial focuses on behavioral intervention through education rather than medication, there are no direct medical side effects. However, participants may experience changes in their healthcare routines.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 14 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 14 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Eye care utilization

Trial Design

1Treatment groups
Experimental Treatment
Group I: Eye concernExperimental Treatment1 Intervention
Those with a diagnosis of glaucoma or glaucoma suspect (or other concerning eye disease, such as diabetic retinopathy or macular degeneration) will be invited to participate in the ComBaT Glaucoma.

Find a Location

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
381 Previous Clinical Trials
1,215,996 Total Patients Enrolled
University of MichiganLead Sponsor
1,795 Previous Clinical Trials
6,373,876 Total Patients Enrolled
7 Trials studying Glaucoma
1,442 Patients Enrolled for Glaucoma
Angela ElamPrincipal InvestigatorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity for participants to enroll in this trial?

"According to clinicaltrials.gov, this medical trial is no longer seeking applicants. The study began on November 1st 2023 and last updated on the 3rd of that same month. However, there are still 192 other trials recruiting patients to participate in their research."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Community Based Treatment for (ComBaT) Glaucoma
Angela Elam 2024. "Community Based Treatment for (ComBaT) Glaucoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06124521.
All > Glaucoma
~40 spots leftby May 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top